top of page

About PhariX

PhariX emerges from pioneering research conducted at ETH Zurich, Empa, and the Balgrist Clinic.

​

We are driven by a vision of surgical care that is faster, safer, and free from avoidable complications. With our laser-based robotic technology, we aim to transform soft tissue wound closure—enabling surgeons to operate with unmatched precision and efficiency. The result: quicker recovery times and better outcomes for patients.

​

Our mission is to redefine soft tissue closure through precision, safety, and innovation.

Who is behind PhariX

Dr. Oscar Cipolato is the founder and driving force behind PhariX. The technology was born out of his doctoral research at ETH Zurich, carried out at The Ingenuity Lab Zurich under the mentorship of Prof. Dr. Inge Herrmann.

  • LinkedIn
IMG_20220412_093747 (2).jpg

PhariX

© 2025 PhariX. All rights reserved.

bottom of page